no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
CME test
|
|
|
2002 |
12 |
3S |
p. 37-43 7 p. |
article |
2 |
Editorial Board
|
|
|
2002 |
12 |
3S |
p. A1- 1 p. |
article |
3 |
Epidermal growth factor receptor as a therapeutic target in head and neck cancer
|
Bonner, James A. |
|
2002 |
12 |
3S |
p. 11-20 10 p. |
article |
4 |
Epidermal growth factor receptor modulation of radiation response: Preclinical and clinical development
|
Harari, Paul M. |
|
2002 |
12 |
3S |
p. 21-26 6 p. |
article |
5 |
Faculty disclosure
|
|
|
2002 |
12 |
3S |
p. 44- 1 p. |
article |
6 |
Farnesyltransferase inhibitors as radiation sensitizers
|
McKenna, W.Gillies |
|
2002 |
12 |
3S |
p. 27-32 6 p. |
article |
7 |
Introduction
|
Lawrence, Theodore S. |
|
2002 |
12 |
3S |
p. 1-2 2 p. |
article |
8 |
Signal transduction pathways: The molecular basis for targeted therapies
|
Ethier, Stephen P. |
|
2002 |
12 |
3S |
p. 3-10 8 p. |
article |
9 |
Small-molecule tyrosine kinase inhibitors as radiosensitizers
|
Lawrence, Theodore S. |
|
2002 |
12 |
3S |
p. 33-36 4 p. |
article |
10 |
Unlabeled uses of commercial products or investigational uses not yet approved
|
|
|
2002 |
12 |
3S |
p. 45- 1 p. |
article |